Article ; Online: Study on tissue distribution, metabolite profiling, and excretion of [
Journal of pharmaceutical and biomedical analysis
2024 Volume 241, Page(s) 115984
Abstract: Flonoltinib Maleate (FM) is a dual-target inhibitor that selectively suppresses Janus kinase 2/FMS-like tyrosine kinase 3 (JAK2/FLT3), which is currently in phase I/IIa clinical trial in China for the treatment of myeloproliferative neoplasms (MPNs). In ... ...
Abstract | Flonoltinib Maleate (FM) is a dual-target inhibitor that selectively suppresses Janus kinase 2/FMS-like tyrosine kinase 3 (JAK2/FLT3), which is currently in phase I/IIa clinical trial in China for the treatment of myeloproliferative neoplasms (MPNs). In this research, we used [ |
---|---|
MeSH term(s) | Rats ; Animals ; Dogs ; Rats, Sprague-Dawley ; Tissue Distribution ; Bile/metabolism ; Feces/chemistry ; Maleates/analysis ; Maleates/metabolism ; Chromatography, High Pressure Liquid/methods ; Administration, Oral |
Chemical Substances | Maleates |
Language | English |
Publishing date | 2024-01-15 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 604917-5 |
ISSN | 1873-264X ; 0731-7085 |
ISSN (online) | 1873-264X |
ISSN | 0731-7085 |
DOI | 10.1016/j.jpba.2024.115984 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1850: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.